Next generation´s test system for faster and more secure biological evaluation of drugs, materials and chemicals
| Reference number | |
| Coordinator | SP SVERIGES TEKNISKA FORSKNINGSINSTITUT AB - SP Kemi, material och ytor, Borås |
| Funding from Vinnova | SEK 9 468 869 |
| Project duration | May 2014 - September 2016 |
| Status | Completed |
| Venture | Challenge-driven innovation - Phase 2 Collaboration |
| Call | Challenge-driven innovation - Stage 2 Collaboration (2014) |
Important results from the project
The project has aimed to develop tissue-specific test systems, to enable faster, cheaper and more efficient progress to final clinical use of novel drugs and medical devices. During the project, two proof-of-concepts for novel test systems has been obtained, and more are expected in the near future. The solutions will be further developed and commercialized by the project´s partners after that the project is finished.
Expected long term effects
Most of the project´s defined targets have been achieved, and a few expected effects 1-3 years after project termination have already begun to incur. The initial scope was very large and involved many different tissues, and all subprojects have not progressed as far. However, several promising solutions have been developed, in particular for blood vessels, bone, kidney, within cancer, and materials for 3D bioprinting. Many solutions and techniques are already implemented by project partners.
Approach and implementation
The project was organised in five work packages focusing on different tissue types. In addition, some subprojects were involving all work packages, e.g. genetic analysis and sensor development. The project appointed a steering group who continuously followed up on the progress and acted as a discussion partner for the project management. This model was successful, as partial projects became visible and partners with common goals and interests were brought together. Project management greatly benefited from having a steering group.